Rapidemic

Rapidemic is a startup based in Leiden, Netherlands, dedicated to developing rapid and decentralized molecular diagnostic technologies, particularly for sexually transmitted infections (STIs) like chlamydia and gonorrhea. The company combines the precision of laboratory-grade testing with the convenience of point-of-care tests, aiming to enhance patient access to quality diagnostics. The team at Rapidemic consists of scientists, engineers, and entrepreneurs committed to innovation in molecular diagnostics. They create molecular point-of-care tests that enable quick, equipment-free diagnosis of STIs in a single visit. These tests provide timely and accurate results, facilitating better treatment decisions and improving STI management in communities. Rapidemic primarily serves healthcare practitioners and public health services that need effective diagnostic tools to control the spread of STIs. Their collaborations with institutions like the University of Maastricht further validate their technology, ensuring it meets the needs of public health initiatives.

• Employees 9
• Founded 2021